News

Printer Friendly Version View printer-friendly version
<< Back
Array BioPharma To Report Financial Results For The Second Quarter Of Fiscal 2015 On February 3, 2015

BOULDER, Colo., Jan. 26, 2015 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq:  ARRY) will report financial results for the second quarter of fiscal 2015 and hold a conference call to discuss those results on Tuesday, February 3, 2015.  Ron Squarer, Chief Executive Officer and Michael Carruthers, Chief Financial Officer will lead the call.

Date:

Tuesday, February 3, 2015

Time:

9:00 a.m. Eastern Time

Toll-Free:

(844) 464-3927

Toll:

(765) 507-2598

Pass Code:

64812242

Webcast, including Replay and Conference Call Slides: http://edge.media-server.com/m/p/s2coayon/lan/en

 

About Array BioPharma
Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer.  Six Phase 3 studies are currently enrolling patients. These programs include two partnered cancer drugs, selumetinib (AstraZeneca) and binimetinib (MEK162 / Novartis).  For more information on Array, please go to www.arraybiopharma.com.

CONTACT:

Tricia Haugeto


Array BioPharma Inc.


(303) 386-1193


thaugeto@arraybiopharma.com

 

Array BioPharma.

Logo - http://photos.prnewswire.com/prnh/20121029/LA02195LOGO

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/array-biopharma-to-report-financial-results-for-the-second-quarter-of-fiscal-2015-on-february-3-2015-300025684.html

SOURCE Array BioPharma Inc.